about
Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamineUntangling tau imagingIn vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133Discrete cortical regions associated with the musical beauty of major and minor chords.Introduction and overview of the special issue "Brain imaging and aging": The new era of neuroimaging in aging research.Geriatric medicine, Japanese Alzheimer's disease neuroimaging initiative and biomarker development.In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice.Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351Applied multimodal diagnostics in a case of presenile dementia.Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans.Recent advances in the development of amyloid imaging agents.Pathobiology of Alzheimer's disease and biomarker development.Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.Tau PET imaging in Alzheimer's disease.In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.Advances in the development of tau PET radiotracers and their clinical applications.18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features.Synthesis and Characterization of ¹⁸F-Interleukin-8 Using a Cell-Free Translation System and 4-¹⁸F-Fluoro-L-Proline.Quantitative kinetic analysis of PET amyloid imaging agents [(11)C]BF227 and [(18)F]FACT in human brain.In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy.Roles of hypothalamic subgroup histamine and orexin neurons on behavioral responses to sleep deprivation induced by the treadmill method in adolescent rats.Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease.Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice.Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.Influence of anesthesia on brain distribution of [(11)C]methamphetamine in monkeys in positron emission tomography (PET) study.Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease.Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease.The effects of a sedative antihistamine, d-chlorpheniramine, on visuomotor spatial discrimination and regional brain activity as measured by positron emission tomography (PET).Neuroanatomical correlates of low body weight in Alzheimer's disease: a PET study.Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
P50
Q24564984-C8DB0038-3362-4FD4-AADF-64447EA67181Q26739091-9D2B0466-C22C-487B-B956-A23A8E43D180Q28270649-DADEBDB5-B3BF-4C2B-BAB3-357E5B4E6B02Q30543903-FF5043F3-B95A-4B32-AFD4-7A380F094717Q31058154-59B05E08-B611-46B1-8346-78DC7767BD55Q33577807-7A53824E-AFF5-42A7-960D-BD00085B4EF2Q34199575-E911A554-C51C-42B5-80D9-E89EE49D0658Q34470555-5C9DF663-C5FD-4B20-B48A-FCDBB4855DD7Q35804873-C0826320-23C2-4769-8796-57D425F0AC88Q35935118-43B2B678-BA63-425E-BE26-12E06667D4DBQ36064072-58E9BFD7-4B55-449B-8D43-5CA80E87911FQ36099506-7B6BC961-82E0-4451-A46B-83B9DA9D9113Q36298335-D095211A-CA1D-4162-81CC-9CE4F2B8D880Q36798485-CDC47E78-8BFF-4E01-8F57-04CC4A9C0047Q36990468-2976BDA9-C530-480A-B734-C5F56A431783Q37675680-F2443014-F365-4CEC-8C6C-9A268F7011EEQ37691087-B3D56CE8-E9D5-4740-8015-0FFB0DF7C1E7Q38252750-86BFEECD-8D90-49E1-8088-8229F66C7176Q38436447-EAB325F9-068A-4DCA-8F40-A2C4DC616469Q38591384-A483DE02-BE26-4932-8FC2-577B2E4100E0Q38708795-E7A175EE-9287-4B60-968F-6E3B57D1335BQ38873939-848D2CC9-7F32-4EDF-8395-E7A36C88D34DQ40131837-8DFBD72D-D30A-483A-964C-A4CC9351354BQ40817470-AD2A9C41-B49B-41A9-81B4-B6C093016B53Q42501142-61AC3ADB-1AE0-4953-B49E-49FA3C2EFD5AQ42501180-47E49411-CD0D-4232-8B1E-D51064CC66BBQ42785136-4CFC44AD-6D8B-41E0-96D6-8642C181629BQ42793320-1512A24F-7068-4683-9ED5-AF8F06838C77Q42928404-1E8E6D6F-D082-4EF2-96AE-1669736713CCQ43233891-DC8F23C5-3928-4A70-AF68-2C6A4E3B68ECQ43270584-8D593A7A-253D-41D5-A23F-4B0FDCACA4B3Q43467553-27961CFC-D8E9-4B24-85B3-AB1B277BCB72Q43569268-673492F4-418E-4CAE-9BB8-4BEFA50C5B7CQ43711781-06016246-197C-4037-8E3E-48B3F3599F6CQ43885735-BC7B6239-CD70-46CA-BC0A-21ECC60FC5F8Q43899469-E5E610E8-9DDE-4E60-973D-E8894429A6B3Q44193631-4A74D7CD-6059-4D09-8758-4E8F09C153C4Q44233164-A94CBB83-C36D-4686-B1D9-5E8FEB3FA771Q44262065-84A76542-8FB4-48FB-9F94-91ED33B1C9DCQ44795513-E6EA46E2-4958-43C0-B547-89DDF87D181E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nobuyuki Okamura
@ast
Nobuyuki Okamura
@en
Nobuyuki Okamura
@es
Nobuyuki Okamura
@nl
Nobuyuki Okamura
@sl
type
label
Nobuyuki Okamura
@ast
Nobuyuki Okamura
@en
Nobuyuki Okamura
@es
Nobuyuki Okamura
@nl
Nobuyuki Okamura
@sl
prefLabel
Nobuyuki Okamura
@ast
Nobuyuki Okamura
@en
Nobuyuki Okamura
@es
Nobuyuki Okamura
@nl
Nobuyuki Okamura
@sl
P106
P1153
22835652700
P21
P31
P496
0000-0002-5991-7812
P569
2000-01-01T00:00:00Z